has received an Establishment Inspection Report (EIR) from the USFDA for its facility in Cuernavaca at Mexico. Reacting to this, the company’s share jumped 2% in the late morning session on Friday.
"The company's API manufacturing facility located in Cuernavaca, Mexico, was recently inspected by the USFDA in compliance with their requirements. The inspection was successful, and the company obtained an EIR. This was a routine inspection by the USFDA," the company said in a press note to the exchanges on Friday.
Vivimed Labs' share price is currently at Rs40.05, up by Rs0.9 or 2.3% from its previous closing of Rs39.15 on the BSE.
The scrip has opened at Rs39.10. It has touched a high and low of Rs42.10 and Rs38.45 respectively. So far 6,51,872 (NSE+BSE) shares were traded on the counter. The current market cap of the company is Rs323.08cr.